Sep 2026· International Journal of Innovative Technologies in Social Science· 0 citations· 22 references
TL;DR
Clinical findings indicate that overall sleep duration and sleep efficiency generally remains unimpaired, and methylphenidate appears to have a promising safety profile regarding the sleep quality and architecture in adult population.
Abstract
Attention-Deficit/Hyperactivity Disorder (ADHD) is a neurodevelopmental condition that is highly prevalent among children. However, the persistence of symptoms of this condition into the adulthood should not be dismissed. The worldwide prevalence of adult ADHD is estimated to affect about 2.5% to 3.4% of the adult population and is associated with severe behavioural, emotional and social disfuncions. Chronic sleep disturbances, most frequently insomnia and deleyed sleep-wake phase disorder, are among the most commonly reported symptoms in adult clinical presentation of ADHD.
In this paper we combined scientific evidence form most recent studies and research papers published between January 2016 and June 2026 concerning the effects of short- and long-acting methylphenidate formulations on sleep quality and sleep-onset latency in adults with ADHD. We searched across PubMed and Google Scholar databases in accordance with predefined methodological inclusion criteria to investigate the connection between stimuland-based pharmacotherapy and sleep efficiency.
Although stimulant pharmacotherapy may prolong sleep-onset latency by approximately 10 to 20 minutes in a subset of patients, clinical findings indicate that overall sleep duration and sleep efficiency generally remains unimpaired. Polysomnographic records further suggest that optimized methylphenidate dosing does not significantly disrupt the microstructure of physiological sleep architecture, including deep sleep (N3) and rapid eye movement (REM) stages. Moreover, modern modified release formulations demonstrate potential benefits in stabilizing circadian regulation, reducing nocturnal racing thoughts and mitigating the evening rebound of ADHD symptoms.
Ultimately, methylphenidate appears to have a promising safety profile regarding the sleep quality and architecture in adult population. Maintaining treatment adherence and improving patients' quality of life require the appropriate use of long-acting formulations, individualized dosage schedules, and consideration of patients' baseline chronotype.
Clinical findings indicate that overall sleep duration and sleep efficiency generally remains unimpaired, and methylphenidate appears to have a promising safety profile regarding the sleep quality and architecture in adult population.
M. Kaczorek, Bożena Kiełbasa, Olga Kowalczyk et al.· 0 citations
An integrative bidirectional model is presented that brings together behavioral, cognitive, and neurobiological findings on the ADHD–sleep relationship across the lifespan and offers an organizing framework for identifying modifiable sleep-related targets in ADHD case formulation and for designing chronotype-informed,...
Introduction: Sleep disturbances are highly prevalent among children and adolescents with attention-deficit/hyperactivity disorder (ADHD). Difficulties initiating sleep, delayed circadian timing, insufficient or irregular sleep, sleep-disordered breathing, restless legs syndrome, and medication-related sleep changes ma...
Raíssa Rodrigues Luz Resende, Ana Beatriz Cardoso Hayden, Andrei Barbosa dos Santos et al.· Revista de Geopolítica· 0 citations
Routine sleep screening should be integrated into the community medicine framework for neurodevelopmental disorders, and longitudinal research in low- and middle-income countries, including India, remains a critical gap.
Jnaneshwari Shantharam, Pragya Yadav, Mahendra Singh· International Journal of Com...· 0 citations
Objective Attention deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention and/or hyperactivity–impulsivity that interferes with functioning or development. Stimulant medication remains its first-line treatment, but perceived ineffectiveness, side effects, and lac...
David S. Im· Journal of Psychiatry & Neur...· 0 citations
To evaluate the short-term and sustained associations between stimulant therapy and insomnia severity and sleep quality in newly diagnosed university students with attention-deficit/hyperactivity disorder (ADHD) and pre-existing sleep disturbances.
16-week prospective cohort study.
Single-centre, univ...
S. Nabeel, Alana Holt· BMJ Connections Mental Healt...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.